iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Update

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totaling 2,307 shares, an increase of 618.7% from the March 31st total of 321 shares. Based on an average daily volume of 3,193 shares, the days-to-cover ratio is presently 0.7 days. Currently, 1.5% of the company’s shares are sold short.

iShares Neuroscience and Healthcare ETF Trading Down 0.5%

Shares of iShares Neuroscience and Healthcare ETF stock traded down $0.16 during trading hours on Friday, reaching $34.48. 1,477 shares of the company’s stock were exchanged, compared to its average volume of 1,974. iShares Neuroscience and Healthcare ETF has a 52-week low of $21.11 and a 52-week high of $37.00. The firm has a market capitalization of $5.17 million, a price-to-earnings ratio of 15.61 and a beta of 0.82. The company has a fifty day moving average of $32.56 and a 200-day moving average of $31.53.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.